Citation: British Journal of Cancer. 2020, 123(5), 691-3. Online ahead of print
Author: Oliver J Pickles, Lennard Y W Lee, Thomas Starkey, Luke Freeman-Mills, Anna Olsson-Brown, Vinton Cheng, Daniel J Hughes, Alvin Lee, Karin Purshouse, Gary Middleton
Abstract: The rapid emergence of COVID-19 has sent shockwaves through healthcare systems globally, with cancer patients at increased risk. The interplay of the virus and host immune system has been implicated in the development of ARDS. Immunotherapy agents have the potential to adversely potentiate this phenomenon, requiring careful real-world observation.
Link to PubMed record
